[Oral administration of cytarabine ocfosfate and ondansetron hydrochloride in patients with acute myeloid leukemia who can not be treated with intensive chemotherapy:--attempt to make their quality of life better].
作者信息
Yano K, Matsui H, Fujisawa S
机构信息
Dept. of Infections Diseases, Hamamatsu Medical Center.